Viral hepatitis is a global epidemic, causing 1.34 million deaths per year. The World Health Organization (WHO) officially endorses World Hepatitis Day (WHD) which takes place on 28th July every year.
Synergy Pharmaceuticals Inc. announced that the FDA has approved Trulance (plecanatide) 3 mg tablet for the once-daily treatment of irritable...
This guideline aims to summarise the current literature guiding the use of red cell transfusion in critically ill patients and provides recommendations to support clinicians in their day-to-day practice.
World Asthma Day aims to raise awareness, to provide care and support for those affected by asthma and extending this to their family, friends and caregivers.
Kala Pharmaceuticals, Inc.announced topline results from Phase III clinical trials (STRIDE - Short Term Relief In Dry Eye).
Phase 111 ADOPT (Apixaban Dosing to Optimize Protection from Thrombosis) trial evaluated Eliquis (apixaban) versus enoxaparin in acutely ill medical...
Sage Therapeutics reported topline results from the pivotal Phase III MOUNTAIN Study evaluating the effect of SAGE 217 (zuranolone) on...
Background: Eculizumab is approved for atypical hemolytic uremic syndrome (aHUS). Guidelines discuss the importance of prompt treatment.
Ocular Therapeutix has announced topline data from the second of two Phase III clinical trials evaluating the safety and efficacy...
Purpose: In obesity and diabetes the liver is highly susceptible to abnormal uptake and storage of fat. In certain individuals hepatic steatosis predisposes to the development of non-alcoholic steatohepatitis (NASH), a disease...